162 related articles for article (PubMed ID: 37365637)
1. Widely targeted quantitative lipidomics and prognostic model reveal plasma lipid predictors for nasopharyngeal carcinoma.
Chen X; Li YX; Cao X; Qiang MY; Liang CX; Ke LR; Cai ZC; Huang YY; Zhan ZJ; Zhou JY; Deng Y; Zhang LL; Huang HY; Li X; Mei J; Xie GT; Guo X; Lv X
Lipids Health Dis; 2023 Jun; 22(1):81. PubMed ID: 37365637
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Deep-Learning Model for Distant Metastasis-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
Zhang L; Wu X; Liu J; Zhang B; Mo X; Chen Q; Fang J; Wang F; Li M; Chen Z; Liu S; Chen L; You J; Jin Z; Tang B; Dong D; Zhang S
J Magn Reson Imaging; 2021 Jan; 53(1):167-178. PubMed ID: 32776391
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of primary gross tumor volume and standardized uptake value of
Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
[TBL] [Abstract][Full Text] [Related]
5. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
6. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
Chen X; Li Y; Li X; Cao X; Xiang Y; Xia W; Li J; Gao M; Sun Y; Liu K; Qiang M; Liang C; Miao J; Cai Z; Guo X; Li C; Xie G; Lv X
Oral Oncol; 2021 Jul; 118():105335. PubMed ID: 34023742
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma.
Liang Y; Li J; Li Q; Tang L; Chen L; Mao Y; He Q; Yang X; Lei Y; Hong X; Zhao Y; He S; Guo Y; Wang Y; Zhang P; Liu N; Li Y; Ma J
Theranostics; 2020; 10(21):9767-9778. PubMed ID: 32863958
[No Abstract] [Full Text] [Related]
9. A Four-Gene Signature Model Improves the Prediction of Distant Metastasis in Patients with Nasopharyngeal Carcinoma: A Retrospective, Three-Center Observational Study.
Si J; Ding X; Deng Z; Li P; Zhang B; Lan G; Huang B; Liang J; Wang Z; Si Y
Technol Cancer Res Treat; 2022; 21():15330338221080972. PubMed ID: 35262435
[No Abstract] [Full Text] [Related]
10. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus DNA change level combined with tumor volume reduction ratio after inductive chemotherapy as a better prognostic predictor in locally advanced nasopharyngeal carcinoma.
Xiang ZZ; He T; Zeng YY; Liu F; Shao BF; Yang T; Ma JC; Wang XR; Yu ST; Liu L
Cancer Med; 2023 Jan; 12(2):1102-1113. PubMed ID: 35852473
[TBL] [Abstract][Full Text] [Related]
12. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
[TBL] [Abstract][Full Text] [Related]
13. A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma.
Li J; Jiang R; Liu WS; Liu Q; Xu M; Feng QS; Chen LZ; Bei JX; Chen MY; Zeng YX
PLoS One; 2013; 8(12):e83069. PubMed ID: 24386144
[TBL] [Abstract][Full Text] [Related]
14. Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes.
Zhou Z; Li P; Zhang X; Xu J; Xu J; Yu S; Wang D; Dong W; Cao X; Yan H; Sun M; Ding X; Xing J; Zhang P; Zhai L; Fan T; Tian S; Yang X; Hu M
Mol Med; 2022 May; 28(1):55. PubMed ID: 35562651
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang H; Zhang R; Zhang R; Zhang B; Xie Y; Qin G; Mo Y; Ruan X; Jiang W
Strahlenther Onkol; 2022 Sep; 198(9):828-837. PubMed ID: 35384452
[TBL] [Abstract][Full Text] [Related]
16. Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.
Yang L; Xia L; Wang Y; Hong S; Chen H; Liang S; Peng P; Chen Y
PLoS One; 2016; 11(7):e0158853. PubMed ID: 27399281
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Circulating Lipoprotein in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
Yao JJ; He XJ; Lawrence WR; Zhang WJ; Kou J; Zhang F; Zhou GQ; Wang SY; Sun Y
Cell Physiol Biochem; 2018; 48(1):285-292. PubMed ID: 30011397
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model combining CD4/CD8 ratio and N stage predicts the risk of distant metastasis for patients with nasopharyngeal carcinoma treated by intensity modulated radiotherapy.
Tao CJ; Chen YY; Jiang F; Feng XL; Jin QF; Jin T; Piao YF; Chen XZ
Oncotarget; 2016 Jul; 7(29):46653-46661. PubMed ID: 27270307
[TBL] [Abstract][Full Text] [Related]
19. High proportion of circulating CD8 + CD28- senescent T cells is an independent predictor of distant metastasis in nasopharyngeal canrcinoma after radiotherapy.
Xu X; Wei F; Xiao L; Wu R; Wei B; Huang S; Yi J; Cui W
J Transl Med; 2023 Jan; 21(1):64. PubMed ID: 36721233
[TBL] [Abstract][Full Text] [Related]
20. A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification.
Xia WX; Zhang HB; Shi JL; Lu X; Wang L; Ye YF; Cao KJ; Qian CN; Guo X; Xiang YQ
Eur J Cancer; 2013 Jun; 49(9):2152-60. PubMed ID: 23571148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
